oncology
Gastric Metaplasia Confers High Risk For Cancer in Study of Mostly White Patients
Patients with gastric intestinal metaplasia had a 19-fold higher risk of developing gastric cancer than those who ...
DECEMBER 9, 2024
New ACG Guideline on Managing Focal Liver Lesions
The American College of Gastroenterology recently released a new clinical guideline on focal liver lesions.
OCTOBER 17, 2024
FDA Approves Next-Gen mt-sDNA test, Cologuard Plus
The FDA has approved the next-generation of the multitarget stool DNA test Cologuard (Exact Sciences).
OCTOBER 9, 2024
New-Onset Diabetes Is an Early Clue to Pancreatic Cancer
New-onset diabetes in adults older than 50 years of age could be a manifestation of pancreatic cancer, according to ...
SEPTEMBER 12, 2024
Latest Updates on Esophageal Fluorescence-Guided Surgery
Esophageal fluorescence-guided surgery has rapidly gained ground.
SEPTEMBER 12, 2024
FDA Approves LONSURF With Bevacizumab for Previously Treated mCRC
The FDA approved trifluridine and tipiracil (LONSURF, Taiho Oncology) with bevacizumab, for previously treated ...
AUGUST 26, 2024
FIT Reduces Deaths From Colorectal Cancer
Evidence is emerging for the power of fecal immunochemical testing to not only reduce colorectal cancer incidence ...
AUGUST 13, 2024
Chemotherapy Before and After Surgery Benefits Patients With Resectable Esophageal Cancer
Chemotherapy before and after surgery for locally advanced esophageal adenocarcinoma improved survival relative to ...
AUGUST 7, 2024
Truseltiq Has FDA Approval Withdrawn for Cholangiocarcinoma
The FDA has announced the final withdrawal of its approval of infigratinib (Truseltiq, QED Therapeutics) for ...
JUNE 24, 2024
Lutathera Approved for Pediatric Patients 12 Years and Older With GEP-NETS
The FDA has approved Lutathera for certain pediatric patients with gastroenteropancreatic neuroendocrine tumors.
APRIL 24, 2024
Center for Young-Onset Colorectal Cancer At Dana-Farber Aims to Meet Unique Challenges
People diagnosed with CRC before 50 years of age comprise a population with its own set of circumstances and needs. ...
APRIL 16, 2024
Evolving CRC Epidemiology Offers Challenges and Opportunities
Over the past few decades, the demographics, location and stage of colorectal cancer at diagnosis have shifted, ...
MARCH 22, 2024
